Refine by
Radiology System Articles & Analysis
21 news found
Potential ways to reduce the contrast media dose with the sharper injection bolus profile from the MEDRADTM Centargo CT Injection System, the latest addition to Bayer’s computed tomography portfolio designed to simplify radiology workflows, are the focus of another presentation at ECR. ...
ByBayer AG
Closing follows announcement of acquisition on January 18, 2023 Acquisition bolsters Bayer’s position in digital medical imaging Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture Bayer today announced that the company has completed the acquisition of the global strategic ...
ByBayer AG
The approval expands Bayer’s radiology portfolio, which includes contrast media, injectors as well as digital and artificial intelligence (AI) enabled solutions, supporting radiologists across a broad range of diseases including breast cancer. ...
ByBayer AG
Acquisition is part of Bayer’s innovation strategy in radiology Blackford Analysis provides cutting-edge radiology AI (artificial intelligence) platform technology Following closing of the acquisition, Blackford Analysis to become part of Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture Bayer today ...
ByBayer AG
The Arktis Radiation Detectors MODES kit is designed to detect and identify radiological threats. The system can work either deployed in vehicles or as a stand-alone static monitor. ...
Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced they are expanding their partnership with Incepto, a leading platform of artificial intelligence solutions for radiology professionals in Europe, by offering their AI applications, SubtleMR and SubtlePET on Incepto’s platform. “We are excited to deepen our existing ...
AI is also bringing clinicians and specialties together to extend the value of radiology to address the #1 killer of women, heart disease. Featured at this year’s event, Kevin Harris, President and co-Founder of CureMetrix, will present new and national research on breast cancer detection and will show how leveraging AI to stratify the risk of Coronary Heart Disease (CHD) ...
n response to President Biden’s relaunch of Cancer Moonshot and his White House commitment to end cancer as we know it, healthcare technology executives for CureMetrix and CureMatch highlighted joint innovation as core to better detection and more personalized cancer treatment. “We commend President Biden’s program to end cancer as we know it, which starts with early detection ...
The technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone Zetagen Therapeutics is developing the therapy for patients living with metastatic bone lesions and other osteologic conditions The Company is targeting its first human clinical trial for metastatic bone lesions to begin in early 2022 Zetagen Therapeutics, a private, ...
VIDA will demo the portal during the Radiological Society of North America (RSNA) annual meeting, which brings together the world's leading radiologists and healthcare system executives, November 28 – December 1, at Booth #4351. ...
CureMetrix, Inc., a global healthcare technology company that develops AI-based software for radiology, will present multiple in-person and virtual sessions at the 2021 Radiological Society of North American (RSNA) Scientific Assembly and Annual Meeting, a hybrid event that will take place both online and live at McCormick Place in Chicago, IL, November 28 to ...
New research finds that artificial intelligence (AI) by CureMetrix, Inc., a global healthcare technology company that develops AI-driven software for radiology, can greatly improve turnaround time for mammogram results and more accurately flag anomalies in a mammogram. The Journal of the American College of Radiology (JACR) has published a case study documenting the two-year, in-practice clinical ...
Christopher Loftus of the FDA's Center for Devices and Radiological Health in a statement. IpsiHand's authorization comes after the FDA reviewed results on patients like Mark Forrest, who had a stroke in 2015. ...
Nipro Medical Corporation (NMC), a leading Renal, Medical, Surgical, and Interventional Radiology products manufacturer, announces the creation of a Vascular Division in the U.S. ...
The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments, Inc. ...
Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment of small coronary artery lesions in Coronary Artery Disease (CAD). The proposed indication for use includes “The ...
The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), announces twelve new Test-Cases which leverage Real-World Evidence (RWE) and address key priorities for medical device stakeholders. ...
The U.S. Food and Drug Administration has announced its approval of the first stand-alone prosthetic iris in the United States that could help patients with certain types of eye damage see clearly and improve their appearance. The surgically implanted device, called the CustomFlex Artificial Iris, is meant to treat adults and children whose iris — the part of the eye that is colored around ...
The National Nuclear Security Administration (NNSA) and the Federal Bureau of Investigation (FBI) announced the completion of a table-top counterterrorism exercise at the National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, N.C. The exercise, Environmental Thunder, was the latest in NNSA’s series of nationwide exercises aimed at giving federal, state and ...
The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) published on January 19, 2011, a “plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical devices.” See FDA News Release, “FDA to improve most common review path for medical devices” (Jan. 19, 2011), available ...